Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/101820

Beta release

Statistics of Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0500
2024-0600
2024-0700